Emergent Biosolutions (EBS) Tops Q4 EPS by 6c, Offers Guidance
Emergent Biosolutions (NYSE: EBS) reported Q4 EPS of $0.42, $0.06 better than the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
